These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19602477)

  • 1. Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
    Kooloos WM; Guchelaar HJ; Huizinga TW; Wessels JA
    Rheumatology (Oxford); 2009 Sep; 48(9):1176-7; author reply 1177. PubMed ID: 19602477
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: The pharmacogenetics of methotrexate.
    van der Kooij SM; Wessels JA; Huizinga TW; Guchelaar HJ
    Rheumatology (Oxford); 2008 Apr; 47(4):557; author reply 5557-8. PubMed ID: 18222982
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway.
    Grabar PB; Rojko S; Logar D; Dolzan V
    Ann Rheum Dis; 2010 May; 69(5):931-2. PubMed ID: 20413572
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?
    Dervieux T
    J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948
    [No Abstract]   [Full Text] [Related]  

  • 5. Race and methotrexate pharmacogenetics in rheumatoid arthritis.
    Ranganathan P; McLeod H
    J Rheumatol; 2010 May; 37(5):1064; author reply 1065. PubMed ID: 20439524
    [No Abstract]   [Full Text] [Related]  

  • 6. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
    Wessels JA; Kooloos WM; De Jonge R; De Vries-Bouwstra JK; Allaart CF; Linssen A; Collee G; De Sonnaville P; Lindemans J; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Sep; 54(9):2830-9. PubMed ID: 16947783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do snapshot statistics fool us in MTX pharmacogenetic studies in arthritis research?
    de Rotte MC; Luime JJ; Bulatovic M; Hazes JM; Wulffraat NM; de Jonge R
    Rheumatology (Oxford); 2010 Jun; 49(6):1200-1. PubMed ID: 20110251
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of methotrexate effects and single-nucleotide polymorphisms in the folate pathway in rheumatoid arthritis: comment on the article by Wessels et al.
    Ranganathan P
    Arthritis Rheum; 2006 Oct; 54(10):3372; author reply 3372-3. PubMed ID: 17009311
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
    Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
    Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false positive report probability.
    Beretta L
    Rheumatology (Oxford); 2009 Dec; 48(12):1619-20; author reply 1620. PubMed ID: 19828599
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al.
    Riksen NP; Rongen GA; Smits P; van Riel P; Barrera P
    Arthritis Rheum; 2007 Feb; 56(2):694; author reply 694-5. PubMed ID: 17265507
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
    Criswell LA; Lum RF; Turner KN; Woehl B; Zhu Y; Wang J; Tiwari HK; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
    Arthritis Rheum; 2004 Sep; 50(9):2750-6. PubMed ID: 15457442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.
    Kooloos WM; Wessels JA; van der Kooij SM; Allaart CF; Huizinga TW; Guchelaar HJ
    Ann Rheum Dis; 2009 Aug; 68(8):1371. PubMed ID: 19605746
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
    Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al.
    Morgan SL; Baggott JE; Alarcón GS
    Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.
    Berkun Y; Levartovsky D; Rubinow A; Orbach H; Aamar S; Grenader T; Abou Atta I; Mevorach D; Friedman G; Ben-Yehuda A
    Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.